1. Home
  2. GDTC vs SLAI Comparison

GDTC vs SLAI Comparison

Compare GDTC & SLAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.02

Market Cap

15.5M

Sector

Health Care

ML Signal

HOLD

SLAI

SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)

N/A

Current Price

$0.88

Market Cap

18.3M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
GDTC
SLAI
Founded
2018
2001
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
15.5M
18.3M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
GDTC
SLAI
Price
$1.02
$0.88
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
173.3K
270.3K
Earning Date
04-24-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$573,193.00
$24,209,000.00
Revenue This Year
$5.37
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
63.03
N/A
52 Week Low
$0.73
$0.63
52 Week High
$3.68
$8.07

Technical Indicators

Market Signals
Indicator
GDTC
SLAI
Relative Strength Index (RSI) 45.90 35.11
Support Level $0.80 $0.85
Resistance Level $0.90 $1.03
Average True Range (ATR) 0.11 0.12
MACD 0.02 0.00
Stochastic Oscillator 73.89 2.69

Price Performance

Historical Comparison
GDTC
SLAI

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About SLAI SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)

SOLAI Ltd is a technology-driven cryptocurrency infrastructure company. It is expanding from its foundation in crypto mining to build a blockchain-based ecosystem spanning AI, stablecoins, and payment infrastructure, and Solana treasury and staking operations supporting use cases across institutional settlement, commerce, consumer payments, and AI-native agent transactions. The group is leveraging its blockchain and data infrastructure expertise, aiming to enhance on-chain efficiency and expand participation across Solana and other blockchain ecosystems.

Share on Social Networks: